v3.25.4
Financial assets and liabilities - Summary of Financial Assets and Liabilities Measured and Recognized at Fair Value (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Financial assets at fair value through other comprehensive income:      
Total Financial Assets $ 1,551 $ 1,388  
Financial liabilities at fair value through profit or loss:      
Contingent consideration 14,138 21,779  
Warrant liabilities 14,172 5,724 $ 4,647
Total Financial Liabilities 28,310 27,503  
Level 1      
Financial assets at fair value through other comprehensive income:      
Total Financial Assets 0 0  
Financial liabilities at fair value through profit or loss:      
Contingent consideration 0 0  
Warrant liabilities 0 0  
Total Financial Liabilities 0 0  
Level 2      
Financial assets at fair value through other comprehensive income:      
Total Financial Assets 0 0  
Financial liabilities at fair value through profit or loss:      
Contingent consideration 0 0  
Warrant liabilities 0 0  
Total Financial Liabilities 0 0  
Level 3      
Financial assets at fair value through other comprehensive income:      
Total Financial Assets 1,551 1,388  
Financial liabilities at fair value through profit or loss:      
Contingent consideration 14,138 21,779  
Warrant liabilities 14,172 5,724  
Total Financial Liabilities 28,310 27,503  
Equity securities - biotech sector      
Financial assets at fair value through other comprehensive income:      
Total Financial Assets 1,551 1,388  
Equity securities - biotech sector | Level 1      
Financial assets at fair value through other comprehensive income:      
Total Financial Assets 0 0  
Equity securities - biotech sector | Level 2      
Financial assets at fair value through other comprehensive income:      
Total Financial Assets 0 0  
Equity securities - biotech sector | Level 3      
Financial assets at fair value through other comprehensive income:      
Total Financial Assets $ 1,551 $ 1,388